Implantable pulse generator market set to reach $245.6B by 2030

The implantable pulse generator market is projected to grow from $147.01 billion in 2025 to $245.56 billion by 2030, driven by rising neurological disorders, chronic pain cases and broader use of neuromodulation therapies. North America held the largest market share in 2025 as demand expanded across implantable medical devices and long-term stimulation treatments.

Why it matters: - Implantable pulse generators are becoming more important as neuromodulation use expands for chronic pain, movement disorders and other long-term conditions. - Market growth signals rising demand for implantable therapies that can deliver targeted electrical stimulation and be adjusted to patient needs.

What happened: - The implantable pulse generator market was valued at $147.01 billion in 2025 and is projected to reach $162.9 billion in 2026. - The market is forecast to grow to $245.56 billion by 2030, with a compound annual growth rate of 10.8%. - North America held the largest share of the market in 2025. - The Business Research Company released its Implantable Pulse Generator Global Market Report 2026 covering market size, trends and forecasts through 2035. - The report includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - An implantable pulse generator is a medical device that delivers electrical impulses to targeted nerves or muscles inside the body. - The device is surgically implanted beneath the skin and can be programmed to adjust stimulation levels. - The technology is used in neuromodulation therapies to help manage chronic pain and movement disorders. - Growth in 2025 and 2026 was driven by chronic pain cases, cardiovascular diseases, broader adoption of implantable medical devices, more hospital surgeries and higher awareness of neuromodulation therapies. - Forecast growth through 2030 is tied to a growing elderly population, a higher burden of neurological disorders, wider access to advanced implantable therapies and greater emphasis on long-term disease management. - Emerging trends include wider use of neuromodulation treatments, stronger demand for rechargeable implantable pulse generators, more applications in movement disorder therapies and continued interest in long-lasting implantable stimulation devices. - One reported growth driver is the rising incidence of neurological disorders, which affect the brain, spinal cord and nervous system. - The World Federation of Neurology reported in October 2023 that more than 40% of the global population has a neurological condition, and that figure is expected to nearly double.

Between the lines: - The market forecast points to a shift from general device adoption toward more specialized, adjustable and durable stimulation systems. - The emphasis on rechargeable devices suggests buyers are looking for lower-maintenance options and longer product lifecycles. - The strong North America position suggests the region remains the main commercial center for these therapies, even as other regions are tracked for expansion.

What's next: - Demand is likely to stay tied to the aging population and the growing number of patients with neurological and chronic pain conditions. - The report points to continued expansion in neuromodulation and movement disorder treatment as key growth areas. - The Business Research Company said its 2026 reports also add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Implantable pulse generator demand is on track for steady double-digit growth as healthcare systems lean more heavily on programmable implantable therapies.